kısım 1 temel kalp yetersizliÄi - Rasim Enar
kısım 1 temel kalp yetersizliÄi - Rasim Enar
kısım 1 temel kalp yetersizliÄi - Rasim Enar
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
138<br />
KANITA DAYALI KALP YETERSİZLİĞİ KİTABI<br />
US Carvedilol Heart Failure Study.<br />
Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits<br />
clinical progression in patients with müd symptoms of heart<br />
failure. US Carvedilol Heart Failure Study Group. Circulation<br />
1996;94(ll):2800-2806.<br />
USCT: US Carvedilol Trial.<br />
Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol<br />
on morbidity and mortality in patients with chronic heart failure.<br />
US Carvedilol Heart Failure Study Group. N. Engl. J. Med.<br />
1996;334:1349-1355.<br />
VHeFT-I, -II: Vasodilators in Heart Failure Trial I, II.<br />
Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator<br />
therapy on mortality in chronic congestive heart failure. Results<br />
of a Veterans Administration Cooperative Study. N.Engl.<br />
J. Med. 1986;314:1547-1552. Cohn JN, Johnson G, Ziesche S, et<br />
al. A comparison of enalapril with hydralazine-isosorbide dinitrate<br />
in the treatment of chronic congestive heart failure. N.<br />
Engl. J. Med. 1991;325:303-310.<br />
ValHeFT: Valsartan Heart Failure Trial.<br />
Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators.<br />
A randomized trial of the angiotensin-receptor blocker valsartan<br />
in chronic heart failure. N. Engl. J. Med. 2001;345(23):1667-<br />
1675.<br />
VALIANT: Valsartan in Acute Myocardial Infarction Trial.<br />
Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan in Acute<br />
Myocardial Infarction Trial Investigators. Valsartan, captopril,<br />
or both in myocardial infarction complicated by heart<br />
failure, left ventricular dysfunction, or both. N. Engl. J. Med.<br />
2003;349(20):1893-1906. Epub 2003 Nov 10.<br />
VEST: Vesnarinone Trial. Cohn JN, Goldstein SO, Greenberg<br />
BH, et al. A dose-dependent increase in mortality with vesnarinone<br />
among patients with severe heart failure. Vesnarinone<br />
Trial Investigators. N. Engl. J. Med. 1998;339:1810-1816.<br />
WARCEF: Warfarin Aspirin Reduced Cardiac Ejection Fraction<br />
Study. Cleland JG, Ghosh J, Freemantle N, et al. Clinical<br />
trials update and cumulative meta-analyses from the American<br />
College of Cardiology: WATCH, SCD-HeFT, DİNAMİT,<br />
CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac<br />
resynchronization therapy in heart failure. Eur. J. Heart Fail.<br />
2004;6(4):501-508.<br />
WATCH: Warfarin and Antiplatelet Therapy in Chronic Heart<br />
Failure.<br />
Cleland JG, Ghosh J, Freemantle N, et al. Clinical trials update<br />
and cumulative meta-analyses from the American College of<br />
Cardiology: WATCH, SCD-HeFT, DİNAMİT, CASINO, INSPI-<br />
RE, STRATUS-US, RIO-Lipids and cardiac resynchronization<br />
therapy in heart failure. Eur. J. Heart Fail. 2004;6(4):501-508.
Change language